T3D Therapeutics Receives $9 Million NIH Grant to Advance Alzheimer's Clinical Trial

Discussion in 'Pharma/Biotech Companies - In the News' started by cafead, May 20, 2019 at 9:52 AM.

  1. #1 cafead, May 20, 2019 at 9:52 AM
    cafead

    cafead Administrator
    Staff Member

    Joined:
    Nov 21, 2001
    Messages:
    32,962
    Likes Received:
    3
    via T3D Therapeutics, based in Research Triangle Park, NC, received a $9 million grant over four years from the National Institute on Aging (NIA), part of the National Institutes of Health (NIH). The funds will be used to partially support a Phase II clinical trial of T3D-959, the company’s novel treatment for Alzheimer’s disease.

    article source
     
    Quote

Reply to Thread